Abstract
Congenital hepatic fibrosis is characterized by hepatic fibrosis, portal hypertension, and renal cystic disease. Typical presentation of congenital hepatic fibrosis is in the form of portal hypertension, in adolescents and young adults. We present an unusual case of neonatal cholestasis with rapid deterioration within first 4 months of life, who was diagnosed to have congenital hepatic fibrosis with polycystic kidney disease on autopsy.
Similar content being viewed by others
References
Poddar U, Thapa BR, Das A, Bhattacharya A, Rao KL, Singh K. Neonatal cholestasis: differentiation of biliary atresia from neonatal hepatitis in a developing country. Acta Paediatr. 2009;98:1260–4.
Ramachandran P, Safwan M, Reddy MS, Rela M. Recent trends in the diagnosis and management of biliary atresia in developing countries. Indian Pediatr. 2015;52:871–9.
Humphrey TM, Stringer MD. Biliary atresia: US diagnosis. Radiology. 2007~244:84551.
Hsiao CH, Chang MH, Chen HL, Lee HC, Wu TC, Lin CC, et al. Universal screening for biliary atresia using an infant stool color card in Taiwan. Hepatology. 2008~47:1233–40.
Mishra A, Pant N, Chadha R, Choudhury SR. Choledochal cysts in infancy and childhood. Indian J Pediatr. 2007;74:937–43.
Ananthakrishnan AN, Saeian K. Caroli’s disease: identification and treatment strategy. Curr Gastroenterol Rep. 2007;9:151–5.
Berry GT. Classic galactosemia and clinical variant galactosemia. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993- 2016. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1518/. Accessed April 13, 2016.
Nazer H, Nazer D. Congenital hepatic fibrosis. Medscape. Updated: Mar 31, 2014. Available from: http://emedicine. medscape.com/article/927984-overview. Accessed April 13, 2016.
Fauvert R, Benhamou JP. Congenital hepatic fibrosis. In: Schaffner F, Sherlock S, Leevy CM, editors. The Liver and its Diseases. New York: Intercontinental Medical Book; 1974. p. 283–8.
Gunay-Aygun M, Gahl WA, Heller T. Congenital Hepatic Fibrosis Overview. 2008 Dec 9 [updated 2014 Apr 24]. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al.; editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016. Available from: http://www.ncbi. nlm.nih.gov/books/NBK2701/PubMed. Accessed April 13, 2016.
Liapis H, Winyard P. Cystic diseases and developmental kidney defects. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Hepinstall’s Pathology of the Kidney. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 1258–1307.
Gunay-Aygun M, Avner ED, Bacallao RL, Choyke PL, Flynn JT, Germino GG, et al. Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference. J Pediatr. 2006;149:159–64.
Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X, et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet. 2002;30:259–69.
Srinath A, Shneider BL. Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease. J Pediatr Gastroenterol Nutr. 2012~54:580–7.
Porubsky S, Kuppe C, Maier T, Birk HW, Wörnle M, Moeller MJ, et al. Renal lipidosis in patients enrolled in a methadone substitution program. Arch Pathol Lab Med. 2014;138:689–93.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bharani, V., Venkatesh, G.V., Saikia, U.N. et al. Congenital hepatic fibrosis with polycystic kidney disease: An unusual cause of neonatal cholestasis. Indian Pediatr 54, 589–592 (2017). https://doi.org/10.1007/s13312-017-1074-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-017-1074-6